HEATHER FRITTS: Open Payments
NPI 1225578123 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,316 in 110 payments from 39 companies in 2025. Trend: 2023 $1,571 · 2024 $2,138 · 2025 $2,316
Food & beverage: $2,233Education: $83
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $353 |
| Novartis Pharmaceuticals Corporation | 15 | $265 |
| Janssen Biotech, Inc. | 11 | $233 |
| BeOne Medicines USA, Inc. | 9 | $169 |
| Merck Sharp & Dohme LLC | 6 | $137 |
| E.R. Squibb & Sons, L.L.C. | 6 | $106 |
| SEAGEN INC. | 1 | $83 |
| Incyte Corporation | 3 | $65 |
| Daiichi Sankyo Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
Products named: IMFINZI, KEYTRUDA, BRUKINSA, LYNPARZA, KISQALI, PLUVICTO, XTANDI, RYBREVANT.
Industry payments across AL — which companies pay providers there.
